Loading clinical trials...
Loading clinical trials...
Diagnostic Study Evaluating the Performance of an Aspergillus-specific Nested PCR Assay in Cerebrospinal Fluid Samples of Immunocompromised Patients for Detection of Central Nervous System Aspergillosis
Multicentre, diagnostic study evaluating the performance of an aspergillus-specific PCR in cerebrospinal fluid samples of immunocompromised patients for identification of central nervous system aspergillosis.
Age
All ages
Sex
ALL
Healthy Volunteers
Yes
Freiburg University Hospital
Freiburg im Breisgau, Baden-Würrtemberg, Germany
Mannheim University Hospital
Mannheim, Baden-Würrtemberg, Germany
Frankfurt (Oder) General Hospital
Frankfurt (Oder), Brandenburg, Germany
Start Date
September 1, 2007
Primary Completion Date
December 1, 2020
Completion Date
December 1, 2020
Last Updated
April 20, 2020
200
ESTIMATED participants
Lead Sponsor
Heidelberg University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions